Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting
-
Patricia Diana Sørensen
Abstract
Background: The purpose of this study was to determine the positive predictive value (PPV) of positive serum human epidermal growth factor receptor-2 (HER-2) for monitoring women with breast cancer following diagnosis and treatment in a routine clinical setting.
Methods: Serum HER-2 was measured in 1348 patients with breast cancer: 837 during routine oncology clinic visits and 511 following new diagnosis. All patients with positive serum HER-2, 1/5 of negative patients from the oncology clinic, and all the newly diagnosed were followed; a total of 862 patients. Serum HER-2 was measured using the Bayer ADVIA Centaur assay. Tissue HER-2 was determined using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). IHC +3 or IHC +2 and FISH>2.0 were positive. Patients were considered to have positive serum HER-2 when at least two values were >15 ng/mL. Recurrence, progression and regression were diagnosed according to usual clinical practice. Serum HER-2 concentrations did not contribute to diagnostic decision-making or selection of treatment.
Results: From January 2004 to January 2009, 149 patients were found to have positive serum HER-2. Of these, 35 were tissue HER-2 positive at surgery, 69 tissue-negative and 45 were not determined. Fifty-five of 149 that were serum HER-2 positive (37%, 95% CI: 29–45) had metastases. Among the 35 tissue-positive patients, 25 had recurrence in the form of metastases and there was good correlation between recurrence/progression and increase in serum HER-2 (p<0.0003). There was also a high correlation between effect of treatment and decline in serum HER-2 (p<0.0003). Of the 69 tissue-negative patients, 29 had recurrence in the form of metastases, and there was good correlation with serum HER-2 levels (p<0.000004). In this routine application of serum HER-2, the PPV for metastases recurrence detection in both tissue-positive and tissue-negative was 54 of 104 (52%, 95% CI: 42%–62%), in tissue-positive 25 of 35 (71%, 95% CI: 54%–85%), in tissue-negative 29 of 69 (42%, 95% CI: 30%–54%). The lead time of increases in serum HER-2 before recurrence could be determined in ten tissue-positive patients was 3–24 months (mean 11.3 months), when compared to standard clinical imaging methods.
Conclusions: Serum HER-2 is a useful marker for the detection of recurrence of breast cancer and for monitoring the effect of treatment, especially in tissue HER-2 positive patients.
Clin Chem Lab Med 2009;47:1117–23.
©2009 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorials
- Estimating glomerular filtration rate
- Serum-free light chain analysis: works in progress
- Review
- Glomerular filtration rate measurement and prediction equations
- Genetics and Molecular Diagnostics
- Leptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
- TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
- Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and risk for pediatric obesity
- Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene
- General Clinical Chemistry and Laboratory Medicine
- Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- Efficiency of test report delivery to the requesting physician in an outpatient setting: an observational study
- A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients
- Preeclamptic placental stress and over expression of mitochondrial HSP70
- Reliability of two different bedside assays for C-reactive protein in newborn infants
- Clinical relevance of circulating midkine in ulcerative colitis
- First automated assay for thyrotropin receptor autoantibodies
- Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
- Cancer Diagnostics
- Serum free light chains: diagnostic and prognostic value in multiple myeloma
- Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies
- Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting
- Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals
- Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients
- Infectious Disease
- Diagnosis of infection with human herpes viruses in routine laboratory practice
- Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest
- Letters to the Editor
- Use of EDTA-plasma gel-separating tubes for measurement of indocyanine green
- Composition of cryoglobulin and cryoprecipitate
- Congress Abstracts
- Congress of Clinical Chemistry and Laboratory Medicine. 6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Leipzig, Germany, October 7–10, 2009
- 8th Panhellenic Clinical Chemistry Congress, Patras, Greece, October 2–4, 2009
Articles in the same Issue
- Editorials
- Estimating glomerular filtration rate
- Serum-free light chain analysis: works in progress
- Review
- Glomerular filtration rate measurement and prediction equations
- Genetics and Molecular Diagnostics
- Leptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
- TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
- Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and risk for pediatric obesity
- Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene
- General Clinical Chemistry and Laboratory Medicine
- Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- Efficiency of test report delivery to the requesting physician in an outpatient setting: an observational study
- A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients
- Preeclamptic placental stress and over expression of mitochondrial HSP70
- Reliability of two different bedside assays for C-reactive protein in newborn infants
- Clinical relevance of circulating midkine in ulcerative colitis
- First automated assay for thyrotropin receptor autoantibodies
- Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
- Cancer Diagnostics
- Serum free light chains: diagnostic and prognostic value in multiple myeloma
- Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies
- Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting
- Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals
- Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients
- Infectious Disease
- Diagnosis of infection with human herpes viruses in routine laboratory practice
- Isolation and expression of UB05, a Plasmodium falciparum antigen recognised by antibodies from semi-immune adults in a high transmission endemic area of the Cameroonian rainforest
- Letters to the Editor
- Use of EDTA-plasma gel-separating tubes for measurement of indocyanine green
- Composition of cryoglobulin and cryoprecipitate
- Congress Abstracts
- Congress of Clinical Chemistry and Laboratory Medicine. 6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Leipzig, Germany, October 7–10, 2009
- 8th Panhellenic Clinical Chemistry Congress, Patras, Greece, October 2–4, 2009
